Fingerprint
Dive into the research topics of 'Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety of the BNT162b2 COVID-19 vaccine in multiple sclerosis (MS): Early experience from a tertiary MS center in Israel
Itay Lotan*, Adi Wilf-Yarkoni, Yitzhak Friedman, Hadas Stiebel-Kalish, Israel Steiner, Mark A. Hellmann
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review